Skip to main content
Top
Published in: Virology Journal 1/2024

Open Access 01-12-2024 | SARS-CoV-2 | Research

Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2

Authors: Annie V. Roy, Michael Chan, Logan Banadyga, Shihua He, Wenjun Zhu, Michel Chrétien, Majambu Mbikay

Published in: Virology Journal | Issue 1/2024

Login to get access

Abstract

Background

Several in silico studies have determined that quercetin, a plant flavonol, could bind with strong affinity and low free energy to SARS-CoV-2 proteins involved in viral entry and replication, suggesting it could block infection of human cells by the virus. In the present study, we examined the ex vivo ability of quercetin to inhibit of SARS-CoV-2 replication and explored the mechanisms of this inhibition.

Methods

Green monkey kidney Vero E6 cells and in human colon carcinoma Caco-2 cells were infected with SARS-CoV-2 and incubated in presence of quercetin; the amount of replicated viral RNA was measured in spent media by RT-qPCR. Since the formation of syncytia is a mechanism of SARS-CoV-2 propagation, a syncytialization model was set up using human embryonic kidney HEK293 co-expressing SARS-CoV-2 Spike (S) protein and human angiotensin converting enzyme 2 (ACE2), [HEK293(S + ACE2) cells], to assess the effect of quercetin on this cytopathic event by microscopic imaging and protein immunoblotting.

Results

Quercetin inhibited SARS-CoV-2 replication in Vero E6 cells and Caco-2 cells in a concentration-dependent manner with a half inhibitory concentration (IC50) of 166.6 and 145.2 µM, respectively. It also inhibited syncytialization of HEK293(S + ACE2) cells with an IC50 of 156.7 µM. Spike and ACE2 co-expression was associated with decreased expression, increased proteolytic processing of the S protein, and diminished production of the fusogenic S2’ fragment of S. Furin, a proposed protease for this processing, was inhibited by quercetin in vitro with an IC50 of 116 µM.

Conclusion

These findings suggest that at low 3-digit micromolar concentrations of quercetin could impair SARS-CoV-2 infection of human cells partly by blocking the fusion process that promotes its propagation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613:130–7.CrossRefPubMed Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613:130–7.CrossRefPubMed
3.
go back to reference Horita N, Fukumoto T. Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic. J Med Virol. 2023;95:e28231.CrossRefPubMed Horita N, Fukumoto T. Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic. J Med Virol. 2023;95:e28231.CrossRefPubMed
4.
go back to reference Ganguli S, Howlader S, Dey K, Barua S, Islam MN, Aquib TI, Partho PB, Chakraborty RR, Barua B, Hawlader MDH, Biswas PK. Association of comorbidities with the COVID-19 severity and hospitalization: a study among the recovered individuals in Bangladesh. Int J Health Sci. 2022;16:30–45. Ganguli S, Howlader S, Dey K, Barua S, Islam MN, Aquib TI, Partho PB, Chakraborty RR, Barua B, Hawlader MDH, Biswas PK. Association of comorbidities with the COVID-19 severity and hospitalization: a study among the recovered individuals in Bangladesh. Int J Health Sci. 2022;16:30–45.
5.
go back to reference Pandey R, Rai D, Tahir MW, Wahab A, Bandyopadhyay D, Lesho E, Laguio-Vila M, Fentanes E, Tariq R, Naidu SS, Aronow WS. Prevalence of comorbidities and symptoms stratified by severity of illness amongst adult patients with COVID-19: a systematic review. Arch Med Sci Atheroscler Dis. 2022;7:e5–e23.CrossRefPubMedPubMedCentral Pandey R, Rai D, Tahir MW, Wahab A, Bandyopadhyay D, Lesho E, Laguio-Vila M, Fentanes E, Tariq R, Naidu SS, Aronow WS. Prevalence of comorbidities and symptoms stratified by severity of illness amongst adult patients with COVID-19: a systematic review. Arch Med Sci Atheroscler Dis. 2022;7:e5–e23.CrossRefPubMedPubMedCentral
6.
go back to reference Ning C, Wang H, Wu J, Chen Q, Pei H, Gao H. The COVID-19 vaccination and vaccine inequity worldwide: an empirical study based on global data. Int J Environ Res Public Health. 2022;19. Ning C, Wang H, Wu J, Chen Q, Pei H, Gao H. The COVID-19 vaccination and vaccine inequity worldwide: an empirical study based on global data. Int J Environ Res Public Health. 2022;19.
7.
go back to reference Sun G, Sui Y, Zhou Y, Ya J, Yuan C, Jiang L, Huang M. Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat. J Virol. 2021;95:e0086121.CrossRefPubMed Sun G, Sui Y, Zhou Y, Ya J, Yuan C, Jiang L, Huang M. Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat. J Virol. 2021;95:e0086121.CrossRefPubMed
8.
go back to reference Gunst JD, Staerke NB, Pahus MH, Kristensen LH, Bodilsen J, Lohse N, Dalgaard LS, Bronnum D, Frobert O, Honge B, et al. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021;35:100849.CrossRefPubMedPubMedCentral Gunst JD, Staerke NB, Pahus MH, Kristensen LH, Bodilsen J, Lohse N, Dalgaard LS, Bronnum D, Frobert O, Honge B, et al. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021;35:100849.CrossRefPubMedPubMedCentral
9.
go back to reference Yuan Z, Pavel MA, Wang H, Kwachukwu JC, Mediouni S, Jablonski JA, Nettles KW, Reddy CB, Valente ST, Hansen SB. Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture. Commun Biol. 2022;5:958.CrossRefPubMedPubMedCentral Yuan Z, Pavel MA, Wang H, Kwachukwu JC, Mediouni S, Jablonski JA, Nettles KW, Reddy CB, Valente ST, Hansen SB. Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture. Commun Biol. 2022;5:958.CrossRefPubMedPubMedCentral
10.
go back to reference Garcia-Albeniz X, Del Amo J, Polo R, Morales-Asencio JM, Hernan MA. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19. Eur J Epidemiol. 2022;37:789–96.CrossRefPubMedPubMedCentral Garcia-Albeniz X, Del Amo J, Polo R, Morales-Asencio JM, Hernan MA. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19. Eur J Epidemiol. 2022;37:789–96.CrossRefPubMedPubMedCentral
11.
12.
go back to reference Konwar M, Maurya M, Bose D. A meta-analysis of safety of different regimens of remdesivir in COVID-19 patients. Curr Drug Saf. 2022;17:158–67.CrossRefPubMed Konwar M, Maurya M, Bose D. A meta-analysis of safety of different regimens of remdesivir in COVID-19 patients. Curr Drug Saf. 2022;17:158–67.CrossRefPubMed
13.
go back to reference Babadaei MMN, Hasan A, Vahdani Y, Bloukh SH, Sharifi M, Kachooei E, Haghighat S, Falahati M. Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. J Biomol Struct Dyn. 2021;39:3771–9.CrossRefPubMed Babadaei MMN, Hasan A, Vahdani Y, Bloukh SH, Sharifi M, Kachooei E, Haghighat S, Falahati M. Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. J Biomol Struct Dyn. 2021;39:3771–9.CrossRefPubMed
14.
go back to reference Najjar-Debbiny R, Gronich N, Weber G, Khoury J, Amar M, Stein N, Goldstein LH, Saliba W. Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients. Clin Infect Dis. 2023;76:e342–9.CrossRefPubMed Najjar-Debbiny R, Gronich N, Weber G, Khoury J, Amar M, Stein N, Goldstein LH, Saliba W. Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients. Clin Infect Dis. 2023;76:e342–9.CrossRefPubMed
15.
go back to reference Hiremath S, Kumar HDV, Nandan M, Mantesh M, Shankarappa KS, Venkataravanappa V, Basha CRJ, Reddy CNL. In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2. 3 Biotech. 2021;11:44.CrossRefPubMedPubMedCentral Hiremath S, Kumar HDV, Nandan M, Mantesh M, Shankarappa KS, Venkataravanappa V, Basha CRJ, Reddy CNL. In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2. 3 Biotech. 2021;11:44.CrossRefPubMedPubMedCentral
16.
go back to reference Pan B, Fang S, Zhang J, Pan Y, Liu H, Wang Y, Li M, Liu L. Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Comput Struct Biotechnol J. 2020;18:3518–27.CrossRefPubMedPubMedCentral Pan B, Fang S, Zhang J, Pan Y, Liu H, Wang Y, Li M, Liu L. Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Comput Struct Biotechnol J. 2020;18:3518–27.CrossRefPubMedPubMedCentral
17.
go back to reference Manjunathan R, Periyaswami V, Mitra K, Rosita AS, Pandya M, Selvaraj J, Ravi L, Devarajan N, Doble M. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein. BMC Bioinform. 2022;23:180.CrossRef Manjunathan R, Periyaswami V, Mitra K, Rosita AS, Pandya M, Selvaraj J, Ravi L, Devarajan N, Doble M. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein. BMC Bioinform. 2022;23:180.CrossRef
18.
go back to reference Zhu J, Declercq J, Creemers JW, Chen C, Cui Y, Van de Ven WJ, Vermorken AJ. Limitations of inhibitory activities of polyphenols on furin-mediated substrate processing. Curr Med Chem. 2012;19:3641–50.CrossRefPubMed Zhu J, Declercq J, Creemers JW, Chen C, Cui Y, Van de Ven WJ, Vermorken AJ. Limitations of inhibitory activities of polyphenols on furin-mediated substrate processing. Curr Med Chem. 2012;19:3641–50.CrossRefPubMed
19.
go back to reference Liu X, Raghuvanshi R, Ceylan FD, Bolling BW. Quercetin and its metabolites inhibit recombinant human angiotensin-converting enzyme 2 (ACE2) activity. J Agric Food Chem. 2020;68:13982–9.CrossRefPubMed Liu X, Raghuvanshi R, Ceylan FD, Bolling BW. Quercetin and its metabolites inhibit recombinant human angiotensin-converting enzyme 2 (ACE2) activity. J Agric Food Chem. 2020;68:13982–9.CrossRefPubMed
20.
go back to reference Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Reyburn HT, Rizzuti B, Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol. 2020;164:1693–703.CrossRefPubMedPubMedCentral Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Reyburn HT, Rizzuti B, Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol. 2020;164:1693–703.CrossRefPubMedPubMedCentral
21.
go back to reference Zhu Y, Scholle F, Kisthardt SC, Xie DY. Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E. Virology. 2022;571:21–33.CrossRefPubMed Zhu Y, Scholle F, Kisthardt SC, Xie DY. Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E. Virology. 2022;571:21–33.CrossRefPubMed
22.
go back to reference Munafo F, Donati E, Brindani N, Ottonello G, Armirotti A, De Vivo M. Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Sci Rep. 2022;12:10571.CrossRefPubMedPubMedCentral Munafo F, Donati E, Brindani N, Ottonello G, Armirotti A, De Vivo M. Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Sci Rep. 2022;12:10571.CrossRefPubMedPubMedCentral
23.
go back to reference Yang D, Wang T, Long M, Li P, Quercetin. Its main pharmacological activity and potential application in clinical medicine. Oxid Med Cell Longev. 2020;2020:8825387.CrossRefPubMedPubMedCentral Yang D, Wang T, Long M, Li P, Quercetin. Its main pharmacological activity and potential application in clinical medicine. Oxid Med Cell Longev. 2020;2020:8825387.CrossRefPubMedPubMedCentral
24.
go back to reference Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-mechanisms and therapeutic targets. Oxid Med Cell Longev. 2021;2021:8671713.CrossRefPubMedPubMedCentral Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-mechanisms and therapeutic targets. Oxid Med Cell Longev. 2021;2021:8671713.CrossRefPubMedPubMedCentral
25.
go back to reference Donnelly MLL, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD. Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip’. J Gen Virol. 2001;82:1013–25.CrossRefPubMed Donnelly MLL, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD. Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip’. J Gen Virol. 2001;82:1013–25.CrossRefPubMed
26.
go back to reference Tsuchiya H. Structure-dependent membrane interaction of flavonoids associated with their bioactivity. Food Chem. 2010;120:1089–96.CrossRef Tsuchiya H. Structure-dependent membrane interaction of flavonoids associated with their bioactivity. Food Chem. 2010;120:1089–96.CrossRef
27.
go back to reference Tsuchiya H. Membrane interactions of phytochemicals as their molecular mechanism applicable to the discovery of drug leads from plants. Molecules. 2015;20:18923–66.CrossRefPubMedPubMedCentral Tsuchiya H. Membrane interactions of phytochemicals as their molecular mechanism applicable to the discovery of drug leads from plants. Molecules. 2015;20:18923–66.CrossRefPubMedPubMedCentral
28.
go back to reference Essalmani R, Jain J, Susan-Resiga D, Andreo U, Evagelidis A, Derbali RM, Huynh DN, Dallaire F, Laporte M, Delpal A, et al. Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity. J Virol. 2022;96:e0012822.CrossRefPubMed Essalmani R, Jain J, Susan-Resiga D, Andreo U, Evagelidis A, Derbali RM, Huynh DN, Dallaire F, Laporte M, Delpal A, et al. Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity. J Virol. 2022;96:e0012822.CrossRefPubMed
29.
go back to reference Carullo G, Badolato M, Aiello F. Bioavailability and biochemistry of quercetin and applications to health and diseases. Polyphenols: mechanisms of action in human health and disease. Elsevier; 2018. pp. 361–71. Carullo G, Badolato M, Aiello F. Bioavailability and biochemistry of quercetin and applications to health and diseases. Polyphenols: mechanisms of action in human health and disease. Elsevier; 2018. pp. 361–71.
30.
go back to reference Paulke A, Eckert GP, Schubert-Zsilavecz M, Wurglics M. Isoquercitrin provides better bioavailability than quercetin: comparison of quercetin metabolites in body tissue and brain sections after six days administration of isoquercitrin and quercetin. Pharmazie. 2012;67:991–6.PubMed Paulke A, Eckert GP, Schubert-Zsilavecz M, Wurglics M. Isoquercitrin provides better bioavailability than quercetin: comparison of quercetin metabolites in body tissue and brain sections after six days administration of isoquercitrin and quercetin. Pharmazie. 2012;67:991–6.PubMed
31.
go back to reference de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC. Tissue distribution of quercetin in rats and pigs. J Nutr. 2005;135:1718–25.CrossRefPubMed de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC. Tissue distribution of quercetin in rats and pigs. J Nutr. 2005;135:1718–25.CrossRefPubMed
32.
go back to reference Furushima D, Otake Y, Koike N, Onishi S, Mori T, Ota N, Yamada H. Investigation of the oral Retention of Tea catechins in humans: an exploratory interventional study. Nutrients. 2021;13. Furushima D, Otake Y, Koike N, Onishi S, Mori T, Ota N, Yamada H. Investigation of the oral Retention of Tea catechins in humans: an exploratory interventional study. Nutrients. 2021;13.
33.
go back to reference Onishi S, Mori T, Kanbara H, Habe T, Ota N, Kurebayashi Y, Suzuki T. Green tea catechins adsorbed on the murine pharyngeal mucosa reduce influenza a virus infection. J Funct Foods. 2020;68:103894.CrossRef Onishi S, Mori T, Kanbara H, Habe T, Ota N, Kurebayashi Y, Suzuki T. Green tea catechins adsorbed on the murine pharyngeal mucosa reduce influenza a virus infection. J Funct Foods. 2020;68:103894.CrossRef
34.
go back to reference Zhang Z, Hao M, Zhang X, He Y, Chen X, Taylor EW, Zhang J. Potential of green tea EGCG in neutralizing SARS-CoV-2 Omicron variant with greater tropism toward the upper respiratory tract. Trends Food Sci Technol. 2023;132:40–53.CrossRefPubMed Zhang Z, Hao M, Zhang X, He Y, Chen X, Taylor EW, Zhang J. Potential of green tea EGCG in neutralizing SARS-CoV-2 Omicron variant with greater tropism toward the upper respiratory tract. Trends Food Sci Technol. 2023;132:40–53.CrossRefPubMed
35.
go back to reference Kandeil A, Mostafa A, Kutkat O, Moatasim Y, Al-Karmalawy AA, Rashad AA, Kayed AE, Kayed AE, El-Shesheny R, Kayali G, Ali MA. Bioactive polyphenolic compounds showing strong antiviral activities against severe acute respiratory syndrome coronavirus 2. Pathogens. 2021;10. Kandeil A, Mostafa A, Kutkat O, Moatasim Y, Al-Karmalawy AA, Rashad AA, Kayed AE, Kayed AE, El-Shesheny R, Kayali G, Ali MA. Bioactive polyphenolic compounds showing strong antiviral activities against severe acute respiratory syndrome coronavirus 2. Pathogens. 2021;10.
36.
go back to reference Chaves OA, Fintelman-Rodrigues N, Wang X, Sacramento CQ, Temerozo JR, Ferreira AC, Mattos M, Pereira-Dutra F, Bozza PT, Castro-Faria-Neto HC et al. Commercially available flavonols are better SARS-CoV-2 inhibitors than isoflavone and Flavones. Viruses. 2022;14. Chaves OA, Fintelman-Rodrigues N, Wang X, Sacramento CQ, Temerozo JR, Ferreira AC, Mattos M, Pereira-Dutra F, Bozza PT, Castro-Faria-Neto HC et al. Commercially available flavonols are better SARS-CoV-2 inhibitors than isoflavone and Flavones. Viruses. 2022;14.
37.
go back to reference Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, et al. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2021;40:e107405.CrossRefPubMedPubMedCentral Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, et al. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2021;40:e107405.CrossRefPubMedPubMedCentral
38.
39.
go back to reference Singh RD, Barry MA, Croatt AJ, Ackerman AW, Grande JP, Diaz RM, Vile RG, Agarwal A, Nath KA. The spike protein of SARS-CoV-2 induces heme oxygenase-1: pathophysiologic implications. Biochim Biophys Acta - Mol Basis Dis. 2022;1868:166322.CrossRefPubMed Singh RD, Barry MA, Croatt AJ, Ackerman AW, Grande JP, Diaz RM, Vile RG, Agarwal A, Nath KA. The spike protein of SARS-CoV-2 induces heme oxygenase-1: pathophysiologic implications. Biochim Biophys Acta - Mol Basis Dis. 2022;1868:166322.CrossRefPubMed
40.
go back to reference Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, Sadegh SE, Tsarouhas K, Kouretas D, Tzanakakis G, et al. Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol Rep. 2017;38:819–28.CrossRefPubMedPubMedCentral Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, Sadegh SE, Tsarouhas K, Kouretas D, Tzanakakis G, et al. Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol Rep. 2017;38:819–28.CrossRefPubMedPubMedCentral
41.
go back to reference Zhu J, Van de Ven WJ, Verbiest T, Koeckelberghs G, Chen C, Cui Y, Vermorken AJ. Polyphenols can inhibit furin in vitro as a result of the reactivity of their auto-oxidation products to proteins. Curr Med Chem. 2013;20:840–50.PubMed Zhu J, Van de Ven WJ, Verbiest T, Koeckelberghs G, Chen C, Cui Y, Vermorken AJ. Polyphenols can inhibit furin in vitro as a result of the reactivity of their auto-oxidation products to proteins. Curr Med Chem. 2013;20:840–50.PubMed
42.
go back to reference de Granada-Flor A, Sousa C, Filipe HAL, Santos M, de Almeida RFM. Quercetin dual interaction at the membrane level. ChemComm. 2019;55:1750–3. de Granada-Flor A, Sousa C, Filipe HAL, Santos M, de Almeida RFM. Quercetin dual interaction at the membrane level. ChemComm. 2019;55:1750–3.
Metadata
Title
Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2
Authors
Annie V. Roy
Michael Chan
Logan Banadyga
Shihua He
Wenjun Zhu
Michel Chrétien
Majambu Mbikay
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
SARS-CoV-2
Published in
Virology Journal / Issue 1/2024
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-024-02299-w

Other articles of this Issue 1/2024

Virology Journal 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine